Prevalence of cardiovascular diseases in China

Frontiers of Medicine in China

Volumn 4, Issue 1, 2010, Pages 16-20

  Xiao, Jun Jie ^a,b   Chen, Yi Han ^a,b  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b TONGJI UNIVERSITY   (China)

Author keywords

Cardiovascular diseases; China; Prevalence; Prevention; Risk factors

Indexed keywords

EID: 76649113757     PISSN: 16737342     EISSN: 16737458     Source Type: Journal    
DOI: 10.1007/s11684-010-0007-8     Document Type: Review

References (41)

1. Wu Y, Huxley R, Li L, Anna V, Xie G, Yao C, Woodward M, Li X, Chalmers J, Gao R, Kong L, Yang X. Prevalence, awareness, treatment, and control of hypertension in China: data from the China national nutrition and health survey 2002. Circulation, 2008, 118(25): 2679-2686.
2. Mark D B, van de Werf F J, Simes R J, White H D, Wallentin L C, Califf R M, Armstrong P W; VIGOUR Group for the VG. Cardiovascular disease on a global scale: defining the path forward for research and practice. Eur Heart J, 2007, 28(21): 2678-2684.
3. Klein W. Cardiovascular disease at the turn of the millennium: focus on Europe. Eur Heart J Suppl, 2001, 3(Supplement M): M2-M6.
4. Hua W, Zhang L F, Wu Y F, Liu X Q, Guo D S, Zhou H L, Gou Z P, Zhao L C, Niu H X, Chen K P, Mai J Z, Chu L N, Zhang S. Incidence of sudden cardiac death in China: analysis of 4 regional populations. J Am Coll Cardiol, 2009, 54(12): 1110-1118.
5. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation, 2001, 104(22): 2746-2753.
6. He Y, Jiang B, Wang J, Feng K, Chang Q, Zhu S, Fan L, Li X, Hu F B. BMI versus the metabolic syndrome in relation to cardiovascular risk in elderly Chinese individuals. Diabetes Care, 2007, 30(8): 2128-2134.
7. He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, Wang J, Chen C S, Chen J, Wildman R P, Klag M J, Whelton P K. Major causes of death among men and women in China. N Engl J Med, 2005, 353(11): 1124-1134.
8. Muntner P, Gu D, Wu X, Duan X, Wenqi G, Whelton P K, He J. Factors associated with hypertension awareness, treatment, and control in a representative sample of the Chinese population. Hypertension, 2004, 43(3): 578-585.
9. Critchley J, Liu J, Zhao D, Wei W, Capewell S. Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999. Circulation, 2004, 110(10): 1236-1244.
10. Zhang X H, Lu Z L, Liu L. Coronary heart disease in China. Heart, 2008, 94(9): 1126-1131.
11. Wu Z, Yao C, Zhao D, Wu G, Wang W, Liu J, Zeng Z, Wu Y. Sino-MONICA project: a collaborative study on trends and determinants in cardiovascular diseases in China, Part I: morbidity and mortality monitoring. Circulation, 2001, 103(3): 462-468.
12. Girmatsion Z, Biliczki P, Bonauer A, Wimmer-Greinecker G, Scherer M, Moritz A, Bukowska A, Goette A, Nattel S, Hohnloser S H, Ehrlich J R. Changes in microRNA-1 expression and I(K1) upregulation in human atrial fibrillation. Heart Rhythm, 2009, 6(12): 1802-1809.
13. Coronel R, Langerveld J, Boersma L V, Wever E F, Bon L, van Dessel P F, Linnenbank A C, van Gilst W H, Ernst S M, Opthof T, van Hemel N M. Left atrial pressure reduction for mitral stenosis reverses left atrial direction dependent conduction abnormalities. Cardiovasc Res, 2009, DOI: 10. 1093/CVR/CVP374.
14. Virtanen J K, Mursu J, Voutilainen S, Tuomainen T P. Serum longchain n-3 polyunsaturated fatty acids and risk of hospital diagnosis of atrial fibrillation in men. Circulation, 2009, 120(23): 2315-2321.
15. Hu D, Sun Y. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China. J Am Coll Cardiol, 2008, 52(10): 865-868.
16. Zhou Z, Hu D. An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of mainland China. J Epidemiol, 2008, 18(5): 209-216.
17. He J, Gu D, Reynolds K, Wu X, Muntner P, Zhao J, Chen J, Liu D, Mo J, Whelton P K. Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China. Circulation, 2004, 110(4): 405-411.
18. Zhang S. Atrial fibrillation in mainland China: epidemiology and current management. Heart, 2009, 95(13): 1052-1055.
19. Pascual-Figal D A, Ordonez-Llanos J, Tornel P L, Vazquez R, Puig T, Valdes M, Cinca J, de Luna A B, Bayes-Genis A. Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction. J Am Coll Cardiol, 2009, 54(23): 2174-2179.
20. George A L Jr. Common genetic variants in sudden cardiac death. Heart Rhythm, 2009, 6(11 Suppl): S3-9.
21. Colquhoun S M, Carapetis J R, Kado J H, Steer A C. Rheumatic heart disease and its control in the Pacific. Expert Rev Cardiovas Ther, 2009, 7(12): 1517-1524.
22. Zhimin W, Yubao Z, Lei S, Xianliang Z, Wei Z, Li S, Hao W, Jianjun L, Detrano R, Rutai H. Prevalence of chronic rheumatic heart disease in Chinese adults. Int J Cardiol, 2006, 107(3): 356-359.
23. Knirsch W, Zingg W, Bernet V, Balmer C, Dimitropoulos A, Pretre R, Bauersfeld U, Latal B. Determinants of body weight gain and association with neurodevelopmental outcome in infants operated for congenital heart disease. Interact Cardiovasc Thorac Surg, 2009, DOI: 10. 1510/icvts. 2009. 216135.
24. Yang X Y, Li X F, Lu X D, Liu Y L. Incidence of congenital heart disease in Beijing, China. Chin Med J (Engl), 2009, 122(10): 1128-1132.
25. Callow A D. Cardiovascular disease 2005-the global picture. Vascul Pharmacol, 2006, 45(5): 302-307.
26. Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P, Huang G, Reynolds R F, Su S, Whelton P K, He J. Prevalence, awareness, treatment, and control of hypertension in china. Hypertension, 2002, 40(6): 920-927.
27. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation, 2001, 104(23): 2855-2864.
28. Gu D, Gupta A, Muntner P, Hu S, Duan X, Chen J, Reynolds R F, Whelton P K, He J. Prevalence of cardiovascular disease risk factor clustering among the adult population of China: results from the International Collaborative Study of Cardiovascular Disease in Asia (InterAsia). Circulation, 2005, 112(5): 658-665.
29. Liu L. Cardiovascular diseases in China. Biochem Cell Biol, 2007, 85(2): 157-163.
30. Cheng T O. The current state of cardiology in China. Int J Cardiol, 2004, 96(3): 425-439.
31. Howard B V, Comuzzie A, Devereux R B, Ebbesson S O, Fabsitz R R, Howard W J, Laston S, Maccluer J W, Silverman A, Umans J G, Wang H, Weissman N J, Wenger C R. Cardiovascular disease prevalence and its relation to risk factors in Alaska Eskimos. Nutr Metab Cardiovasc Dis, 2009, DOI: 10. 1016/j.
32. Liu M, Wu B, Wang W Z, Lee L M, Zhang S H, Kong L Z. Stroke in China: epidemiology, prevention, and management strategies. Lancet Neurol, 2007, 6(5): 456-464.
33. Berger J S, Bhatt D L, Steinhubl S R, Shao M, Steg P G, Montalescot G, Hacke W, Fox K A, Lincoff A M, Topol E J, Berger P B. Smoking, clopidogrel, and mortality in patients with established cardiovascular disease. Circulation, 2009, 120(23): 2337-2344.
34. Hu J, Wallace D C, Jones E, Liu H. Cardiometabolic health of Chinese older adults with diabetes living in Beijing, China. Public Health Nurs, 2009, 26(6): 500-511.
35. Cheng T O. Smoking and diabetes in Chinese men. Postgrad Med J, 2001, 77(910): 551.
36. Gu D, Wu X, Reynolds K, Duan X, Xin X, Reynolds R F, Whelton P K, He J. Cigarette smoking and exposure to environmental tobacco smoke in China: the international collaborative study of cardiovascular disease in Asia. Am J Public Health, 2004, 94(11): 1972-1976.
37. McGuire K A, Janssen I, Ross R. Ability of physical activity to predict cardiovascular disease beyond commonly evaluated cardiometabolic risk factors. Am J Cardiol, 2009, 104(11): 1522-1526.
38. Fu F H, Fung L. The cardiovascular health of residents in selected metropolitan cities in China. Prev Med, 2004, 38(4): 458-467.
39. Kelly T N, Gu D, Chen J, Huang J F, Chen J C, Duan X, Wu X, Yau C L, Whelton P K, He J. Hypertension subtype and risk of cardiovascular disease in Chinese adults. Circulation, 2008, 118(15): 1558-1566.
40. Lee D E, Cooper R S. Recommendations for global hypertension monitoring and prevention. Curr Hypertens Rep, 2009, 11(6): 444-449.
41. Tang J L, Hu Y H. Drugs for preventing cardiovascular disease in China. BMJ, 2005, 330(7492): 610-611.